These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 773531)

  • 21. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
    Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E
    Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds.
    Witte AB; Anestål K; Jerremalm E; Ehrsson H; Arnér ES
    Free Radic Biol Med; 2005 Sep; 39(5):696-703. PubMed ID: 16085187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of hematologic toxicity of antineoplastic agents with their effects on bone marrow stem cells: interspecies studies using an in vivo assay.
    Marsh JC
    Exp Hematol; 1985; 13 Suppl 16():16-22. PubMed ID: 3987835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effect of various cytostatic drugs on the growth of 12 chosen mycobacterial strains].
    Schwartz E
    Prax Pneumol; 1971 May; 25(5):278-86. PubMed ID: 5556356
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparison of the three in vivo assays for haemopoietic stem cells.
    Dunn CD; Constable TB
    Acta Haematol; 1973; 50(1):9-18. PubMed ID: 4200802
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of chemotherapeutic agents on the immune response. II.
    Kempf RA; Mitchell MS
    Cancer Invest; 1985; 3(1):23-33. PubMed ID: 2578859
    [No Abstract]   [Full Text] [Related]  

  • 27. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
    Kim K; Blechman WJ; Riddle VG; Pardee AB
    Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The action of cyclo-specific and non-cyclo-specific antineoplastic agents on hematopoietic CFU in mice after bloodletting].
    Saviane A; Massa G; Bogliolo G; Pannacciulli I
    Boll Soc Ital Biol Sper; 1976 Mar; 52(6):465-8. PubMed ID: 949426
    [No Abstract]   [Full Text] [Related]  

  • 29. [Human tumor clonogenic assay in human breast cancer].
    Kobayashi T; Kuraishi Y; Aiba K; Inoue K
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1566-72. PubMed ID: 3927846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of various cytotoxic agents on the erythroid precursors in rat bone marrow.
    Millar JL; Blackett NM
    Br J Haematol; 1974 Apr; 26(4):535-41. PubMed ID: 4845646
    [No Abstract]   [Full Text] [Related]  

  • 31. Combination chemotherapy in vitro with cis-dichlorodiammineplatinum(II).
    Drewinko B; Green C; Loo TL
    Cancer Treat Rep; 1976 Nov; 60(11):1619-25. PubMed ID: 1021234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of the effects of alkylating agents, antimetabolites and antineoplastic agents of other types on hemopoietic CFU in mice].
    Massa G; Saviane A; Bogliolo G; Pannacciulli I
    Boll Soc Ital Biol Sper; 1976 Mar; 52(6):460-4. PubMed ID: 949425
    [No Abstract]   [Full Text] [Related]  

  • 33. Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents.
    Pogrebniak A; Schemainda I; Azzam K; Pelka-Fleischer R; Nüssler V; Hasmann M
    Eur J Med Res; 2006 Aug; 11(8):313-21. PubMed ID: 17052966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Detection of a moderate staphylococcal phage by means of antineoplastic agents].
    Smolianskaia AZ; Leĭkina FI
    Antibiotiki; 1970 Jun; 15(6):514-9. PubMed ID: 4195833
    [No Abstract]   [Full Text] [Related]  

  • 35. Differential sensitivity to mitomycin C between human RSa cell line and its derivative UVr-1.
    Hiwasa T; Chen Z; Nomura J; Yamamori H; Tashiro T; Nakajima N; Suzuki N
    Anticancer Res; 1999; 19(5B):3915-20. PubMed ID: 10628331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hematopoietic precursor cell exhaustion is a cause of proliferative defect in primitive hematopoietic stem cells (PHSC) after chemotherapy.
    Gardner RV; Astle CM; Harrison DE
    Exp Hematol; 1997 Jun; 25(6):495-501. PubMed ID: 9197327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct effects of chemotherapeutic agents on rat prostate tumor clonogenic cells.
    Geldof AA; Rao BR; de Voogt HJ
    Anticancer Res; 1986; 6(4):837-40. PubMed ID: 3752961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
    Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxic synergy between flavopiridol (NSC 649890, L86-8275) and various antineoplastic agents: the importance of sequence of administration.
    Bible KC; Kaufmann SH
    Cancer Res; 1997 Aug; 57(16):3375-80. PubMed ID: 9269999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.